Detalhe da pesquisa
1.
Correction: The increasing incidence of visceral leishmaniasis relapse in South Sudan: A retrospective analysis of field patient data from 2001-2018.
PLoS Negl Trop Dis
; 18(2): e0011952, 2024 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-38346002
2.
The increasing incidence of visceral leishmaniasis relapse in South Sudan: A retrospective analysis of field patient data from 2001-2018.
PLoS Negl Trop Dis
; 16(8): e0010696, 2022 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-35981057
3.
Outcomes of visceral leishmaniasis in pregnancy: A retrospective cohort study from South Sudan.
PLoS Negl Trop Dis
; 14(1): e0007992, 2020 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-31978116
4.
Treatment of kala-azar in southern Sudan using a 17-day regimen of sodium stibogluconate combined with paromomycin: a retrospective comparison with 30-day sodium stibogluconate monotherapy.
Am J Trop Med Hyg
; 77(1): 89-94, 2007 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-17620635
5.
A clinical severity scoring system for visceral leishmaniasis in immunocompetent patients in South Sudan.
PLoS Negl Trop Dis
; 11(10): e0005921, 2017 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-28968400
6.
A Comparison of the Effectiveness of Sodium Stibogluconate Monotherapy to Sodium Stibogluconate and Paromomycin Combination for the Treatment of Severe Post Kala Azar Dermal Leishmaniasis in South Sudan - A Retrospective Cohort Study.
PLoS One
; 11(9): e0163047, 2016.
Artigo
em Inglês
| MEDLINE | ID: mdl-27658288
7.
Visceral leishmaniasis relapse in Southern Sudan (1999-2007): a retrospective study of risk factors and trends.
PLoS Negl Trop Dis
; 4(6): e705, 2010 Jun 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-20544032